Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.6.5, has been added to the study record history. The previous revision, v3.6.4, has been removed from the history, reflecting the latest version of the record.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe history now includes Revision: v3.6.4, with the previous Revision: v3.6.3 removed. This appears to be a minor revision to the page history rather than an update to study data.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Record History view now displays an expanded sequence of past versions and release-note style entries, and the footer/navigation has been updated to include additional links and site information.SummaryDifference77%

- Check37 days agoChange DetectedThe latest version of the study history page removes the site footer and associated navigation/release-notes elements, resulting in a cleaner, more minimal layout.SummaryDifference17%

- Check44 days agoChange DetectedThe Record History view adds a Compare control and a Study Status section, and the revision list includes newer entries up to 2026-06-04, reflecting updated navigation and organization of study revisions.SummaryDifference44%

- Check59 days agoChange DetectedThe study record now shows that recruitment is no longer ongoing, impacting who can enroll. A new Revision: v3.6.0 has been added to the history, signaling an updated version of the record.SummaryDifference0.2%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.